Dublin, May 07, 2019 (GLOBE NEWSWIRE) -- The "Plasma Protein Therapeutics Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2024" report has been added to ResearchAndMarkets.com's offering.

This report on the global plasma protein therapeutics market provides qualitative and quantitative analysis for the period from 2016 to 2024. The report predicts the global plasma protein therapeutics market to grow with a CAGR of 6.1% over the forecast period from 2018-2024. The study on plasma protein therapeutics market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and RoW for the period of 2016 to 2024.

The report on plasma protein therapeutics market is a comprehensive study and presentation of drivers, restraints, opportunities, demand factors, market size, forecasts, and trends in the global plasma protein therapeutics market over the period of 2016 to 2024. Moreover, the report is a collective presentation of primary and secondary research findings.

Porter's five forces model in the report provides insights into the competitive rivalry, supplier and buyer positions in the market and opportunities for the new entrants in the global plasma protein therapeutics market over the period of 2016 to 2024. In addition, the growth matrix given in the report brings an insight into the investment areas that existing or new market players can consider.

Report Findings

1. Drivers

• Growing demand of the plasma proteins derived medicines
• Continuous innovation in plasma-derived therapies

2. Restraints

• Stringent rules and regulation for plasma protein therapeutics
• Issues related to reimbursements

3. Opportunities

• Increasing demand for plasma-derived treatments
• Continuous growth in medical tourism in developing countries

Key Topics Covered:

1. Preface
1.1. Report Description
1.2. Research Methods
1.3. Research Approaches

2. Executive Summary
2.1. Plasma Protein Therapeutics Market Highlights
2.2. Plasma Protein Therapeutics Market Projection
2.3. Plasma Protein Therapeutics Market Regional Highlights

3. Global Plasma Protein Therapeutics Market Overview
3.1. Introduction
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
3.3. Porter's Five Forces Analysis
3.4. Growth Matrix Analysis
3.4.1. Growth Matrix Analysis by Product
3.4.2. Growth Matrix Analysis by Application
3.4.3. Growth Matrix Analysis by Region
3.5. Value Chain Analysis of Plasma Protein Therapeutics Market

4. Plasma Protein Therapeutics Market Macro Indicator Analysis

5. Global Plasma Protein Therapeutics Market by Product
5.1. Albumins
5.2. Immunoglobulins
5.3. C1-esterase Inhibitors
5.4. Hyperimmune Globulins
5.5. Coagulation Factors

6. Global Plasma Protein Therapeutics Market by Application
6.1. Idiopathic Thrombocytopenic Purpura
6.2. Hereditary Angioedema
6.3. Secondary Immunodeficiency
6.4. Primary Immunodeficiency Disorder
6.5. Other Indications

7. Global Plasma Protein Therapeutics Market by Region 2018-2024

8. Company Profiles and Competitive Landscape
8.1. Competitive Landscape in the Global Plasma Protein Therapeutics Market
8.2. Companies Profiles
8.2.1. Shire
8.2.2. Octapharma USA, Inc.
8.2.3. Grifols, S.A.
8.2.4. China Biologic Products Holdings, Inc.
8.2.5. CSL Behring
8.2.6. Biotest AG
8.2.7. Baxter
8.2.8. Chengdu Institute of Biology (CIB)

9. Appendix

For more information about this report visit https://www.researchandmarkets.com/r/bu71u

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

CONTACT: ResearchAndMarkets.com
         Laura Wood, Senior Press Manager
         press@researchandmarkets.com
         For E.S.T Office Hours Call 1-917-300-0470
         For U.S./CAN Toll Free Call 1-800-526-8630
         For GMT Office Hours Call +353-1-416-8900
Related Topics: Biopharmaceuticals 

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.